Clover Health Investments, Corp.
CLOV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,371 | $1,261 | $1,097 | $1,472 |
| % Growth | 8.8% | 15% | -25.5% | – |
| Cost of Goods Sold | $1,006 | $1,005 | $993 | $1,551 |
| Gross Profit | $365 | $256 | $103 | -$79 |
| % Margin | 26.6% | 20.3% | 9.4% | -5.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $409 | $440 | $482 | $446 |
| SG&A Expenses | $409 | $440 | $482 | $446 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | $21 | -$92 | $112 |
| Operating Expenses | $411 | $461 | $390 | $558 |
| Operating Income | -$46 | -$205 | -$287 | -$637 |
| % Margin | -3.3% | -16.3% | -26.1% | -43.3% |
| Other Income/Exp. Net | -$1 | -$5 | $32 | $49 |
| Pre-Tax Income | -$46 | -$210 | -$255 | -$588 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$43 | -$213 | -$340 | -$588 |
| % Margin | -3.1% | -16.9% | -31% | -39.9% |
| EPS | -0.088 | -0.45 | -0.71 | -1.25 |
| % Growth | 80.5% | 36.6% | 43.2% | – |
| EPS Diluted | -0.088 | -0.45 | -0.71 | -1.25 |
| Weighted Avg Shares Out | 490 | 482 | 476 | 471 |
| Weighted Avg Shares Out Dil | 490 | 482 | 476 | 471 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $1 | $17 |
| Depreciation & Amortization | $1 | $3 | $1 | $1 |
| EBITDA | -$45 | -$208 | -$252 | -$570 |
| % Margin | -3.3% | -16.5% | -23% | -38.7% |